Join

Compare · QNRX vs WST

QNRX vs WST

Side-by-side comparison of Quoin Pharmaceuticals Ltd. (QNRX) and West Pharmaceutical Services Inc. (WST): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both QNRX and WST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • WST is the larger of the two at $23.64B, about 2378.2x QNRX ($9.9M).
  • Over the past year, QNRX is down 45.4% and WST is up 47.1% - WST leads by 92.5 points.
  • Both names hit the wire about 5 times in the past 4 weeks.
  • WST has more recent analyst coverage (17 ratings vs 0 for QNRX).
PerformanceQNRX-45.40%WST+47.10%
2025-06-10+0.00%2026-06-09
MetricQNRXWST
Company
Quoin Pharmaceuticals Ltd.
West Pharmaceutical Services Inc.
Price
$4.81+3.89%
$334.67+4.58%
Market cap
$9.9M
$23.64B
1M return
-23.77%
+2.67%
1Y return
-45.40%
+47.10%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
2016
News (4w)
5
5
Recent ratings
0
17
QNRX

Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

WST

West Pharmaceutical Services Inc.

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Latest QNRX

Latest WST